JD. MS, Ph.D.

Dr. Lawrence is an American biogerontologist with a Jurisprudence
Degree (UCLA-Law), an MS in Psychology, and a Ph.D. in Nutritional
Science. For three decades, his focus has been human longevity
research and interventions for optimal life and healthspan.

Dr. Lawrence has been affiliated with the St. Petersburg Institute of
Bioregulation and Gerontology (Russia) since 2015. He administers two
Russian and American longevity clinical studies: Telomerase activation
and DNA/Methylation modification. These studies use Khavinson
Peptide Bioregulators, developed by Prof. Vladimir Khavinson of the St.
Petersburg Institute, to reverse human aging.

In his presentation, Dr. Lawrence, as a scientist and attorney, will report
clinical study data and scientific evidence confirming Peptide
Bioregulators reverse human biological age. He will also present clinical
study data confirming the SARS-CoV-2 virus and vaccines accelerate
biological aging.

Dr. Lawrence is chronologically 76. His average telomere length, or
“cellular age,” is equivalent to a 45-year-old. His present “Epigenetic
Age” measured by the Horvath Epigenetic Clock (DNA/Methylation) is
associated with a fifty percent reduction of all-cause mortality risk
compared to his same-age peers.